News and Trends on Pharma Industry Production & Manufacturing

Holista Launches Collagen Production JV With SCC in Collie

Yuvraj — Thu, 14 May 2026 08:12:06 +0000

Holista Colltech Limited has entered into a binding joint venture agreement with Swang Chai Chuan Limited to establish and operate an ovine nano-collagen manufacturing facility in Collie, Western Australia. The project will be carried out through Ovicoll Pty Ltd, which will initially be owned equally by both parties under a 50:50 structure. Under the agreement, […]

The post Holista Launches Collagen Production JV With SCC in Collie first appeared on World Pharma Today.

AddParts Secures Funding for Pharma Manufacturing Resilience

Yuvraj — Sat, 09 May 2026 06:20:26 +0000

AddParts, a UK-based technology company focused on improving operational continuity in pharmaceutical production environments, has secured a six-figure pre-seed investment from SFC Capital to support the expansion of its virtual storeroom technology. Announced on 29 April 2026 in Sheffield, the funding will support the continued development of the company’s platform, which is designed to help […]

The post AddParts Secures Funding for Pharma Manufacturing Resilience first appeared on World Pharma Today.

Made Smarter Advances AI in Manufacturing with New Toolkit

Yuvraj — Wed, 06 May 2026 10:14:04 +0000

A new initiative from Made Smarter is aiming to simplify how manufacturers approach artificial intelligence, with a focus on practical deployment rather than theoretical potential. The organisation has introduced a downloadable guide titled AI Adoption in Manufacturing: A Practical Toolkit from Made Smarter, designed specifically to support SME leaders as they navigate the growing relevance […]

The post Made Smarter Advances AI in Manufacturing with New Toolkit first appeared on World Pharma Today.

Designing Biotech Financial Models for Series B Success

Yuvraj — Mon, 27 Apr 2026 08:43:12 +0000

Building a compelling Series B case in biopharma goes well beyond efficacy data and market size projections. Sophisticated investors are increasingly focused on CMC risk, licensing obligations, and the defensibility of your manufacturing timeline. This article breaks down what the financial model behind a strong Series B actually looks like and what quietly kills deals that should have worked.

The post Designing Biotech Financial Models for Series B Success first appeared on World Pharma Today.

CMC Bottleneck in Drug Development and IND Delays

Yuvraj — Mon, 27 Apr 2026 06:39:46 +0000

Ask any experienced biopharma program manager what derails an IND filing most often, and the answer is rarely surprising: it is CMC. Not insufficient efficacy data, not toxicology surprises CMC. This article examines why Chemistry, Manufacturing, and Controls continues to be the most underestimated risk in early drug development, and what program leaders can do about it.

The post CMC Bottleneck in Drug Development and IND Delays first appeared on World Pharma Today.

Gene Expression Systems Explained for Biotech Founders

Yuvraj — Fri, 24 Apr 2026 11:06:47 +0000

Choosing a gene expression system is one of the earliest and most consequential manufacturing decisions a biotech founder will make yet it is often made without fully understanding what is at stake. This article breaks down the key expression platforms used in biologic drug development, what differentiates them technically and commercially, and why the choice you make now will follow your program all the way to the clinic and beyond.

The post Gene Expression Systems Explained for Biotech Founders first appeared on World Pharma Today.

AbbVie to Invest $1.4B in North Carolina Manufacturing Plant

Yuvraj — Fri, 24 Apr 2026 07:25:13 +0000

AbbVie has outlined plans to build a major new manufacturing facility in Durham, committing $1.4 billion to what will become its largest single-campus capital investment to date. The project, spread across 185 acres, is expected to generate more than 730 jobs and will support the production of medicines across the company’s immunology, neuroscience and oncology […]

The post AbbVie to Invest $1.4B in North Carolina Manufacturing Plant first appeared on World Pharma Today.

AbbVie Secures $745M Haisco Deal to Expand Pain Drug Pipeline

Yuvraj — Thu, 16 Apr 2026 10:05:22 +0000

AbbVie has entered into a global licensing agreement with China-based Haisco Pharmaceutical valued at up to $715 million, aiming to strengthen its presence in pain therapeutics. The Haisco deal grants AbbVie exclusive rights to develop, manufacture, and commercialize multiple investigational compounds worldwide, excluding mainland China, Hong Kong, and Macau. These assets, spanning preclinical through Phase […]

The post AbbVie Secures $745M Haisco Deal to Expand Pain Drug Pipeline first appeared on World Pharma Today.

Novo Nordisk OpenAI Partnership Accelerates Drug Development

Yuvraj — Wed, 15 Apr 2026 12:24:16 +0000

Danish pharmaceutical major Novo Nordisk has entered into a strategic collaboration with OpenAI to embed artificial intelligence across its drug development operations, with the stated goal of accelerating the delivery of new treatments. Announced on Tuesday, the initiative is designed to strengthen the company’s ability to identify and advance therapies more efficiently, particularly in areas […]

The post Novo Nordisk OpenAI Partnership Accelerates Drug Development first appeared on World Pharma Today.

Smart Sensors Elevating Pharma Process Control Systems

Yuvraj — Mon, 13 Apr 2026 10:26:29 +0000

The deployment of intelligent sensing technology is fundamentally reshaping how pharmaceutical manufacturers manage complex production environments. By providing granular, real-time data at critical control points, these advanced instruments allow for instantaneous process adjustments, ensuring that every batch meets the most rigorous standards of quality and safety.

The post Smart Sensors Elevating Pharma Process Control Systems first appeared on World Pharma Today.